191 related articles for article (PubMed ID: 20940257)
21. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro.
Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J
Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932
[TBL] [Abstract][Full Text] [Related]
22. Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme.
Kulyk WM; Franklin JL; Hoffman LM
Exp Cell Res; 2000 Mar; 255(2):327-32. PubMed ID: 10694448
[TBL] [Abstract][Full Text] [Related]
23. Enamel matrix derivative stimulates chondrogenic differentiation of ATDC5 cells.
Narukawa M; Suzuki N; Takayama T; Shoji T; Otsuka K; Ito K
J Periodontal Res; 2007 Apr; 42(2):131-7. PubMed ID: 17305871
[TBL] [Abstract][Full Text] [Related]
24. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
25. The effects of Sp7/Osterix gene silencing in the chondroprogenitor cell line, ATDC5.
Omoteyama K; Takagi M
Biochem Biophys Res Commun; 2010 Dec; 403(2):242-6. PubMed ID: 21075078
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9.
Robins JC; Akeno N; Mukherjee A; Dalal RR; Aronow BJ; Koopman P; Clemens TL
Bone; 2005 Sep; 37(3):313-22. PubMed ID: 16023419
[TBL] [Abstract][Full Text] [Related]
27. [Transcriptional regulation in chondrogenesis by Sox9].
Akiyama H
Clin Calcium; 2011 Jun; 21(6):845-51. PubMed ID: 21628799
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
29. THRAP3 interacts with and inhibits the transcriptional activity of SOX9 during chondrogenesis.
Sono T; Akiyama H; Miura S; Deng JM; Shukunami C; Hiraki Y; Tsushima Y; Azuma Y; Behringer RR; Matsuda S
J Bone Miner Metab; 2018 Jul; 36(4):410-419. PubMed ID: 28770354
[TBL] [Abstract][Full Text] [Related]
30. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice.
Hata K; Nishimura R; Muramatsu S; Matsuda A; Matsubara T; Amano K; Ikeda F; Harley VR; Yoneda T
J Clin Invest; 2008 Sep; 118(9):3098-108. PubMed ID: 18677406
[TBL] [Abstract][Full Text] [Related]
31. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1.
Majumdar MK; Wang E; Morris EA
J Cell Physiol; 2001 Dec; 189(3):275-84. PubMed ID: 11748585
[TBL] [Abstract][Full Text] [Related]
32. The homeobox transcription factor Barx2 regulates chondrogenesis during limb development.
Meech R; Edelman DB; Jones FS; Makarenkova HP
Development; 2005 May; 132(9):2135-46. PubMed ID: 15800003
[TBL] [Abstract][Full Text] [Related]
33. Interference by adrenaline with chondrogenic differentiation through suppression of gene transactivation mediated by Sox9 family members.
Takarada T; Hojo H; Iemata M; Sahara K; Kodama A; Nakamura N; Hinoi E; Yoneda Y
Bone; 2009 Sep; 45(3):568-78. PubMed ID: 19446054
[TBL] [Abstract][Full Text] [Related]
34. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.
Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K
Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells.
Nochi H; Sung JH; Lou J; Adkisson HD; Maloney WJ; Hruska KA
J Bone Miner Res; 2004 Jan; 19(1):111-22. PubMed ID: 14753743
[TBL] [Abstract][Full Text] [Related]
36. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
Wenke AK; Grässel S; Moser M; Bosserhoff AK
FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
[TBL] [Abstract][Full Text] [Related]
37. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.
Otero M; Peng H; Hachem KE; Culley KL; Wondimu EB; Quinn J; Asahara H; Tsuchimochi K; Hashimoto K; Goldring MB
Connect Tissue Res; 2017 Jan; 58(1):15-26. PubMed ID: 27310669
[TBL] [Abstract][Full Text] [Related]
38. SOX9 directly regulates the type-II collagen gene.
Bell DM; Leung KK; Wheatley SC; Ng LJ; Zhou S; Ling KW; Sham MH; Koopman P; Tam PP; Cheah KS
Nat Genet; 1997 Jun; 16(2):174-8. PubMed ID: 9171829
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells.
Ushita M; Saito T; Ikeda T; Yano F; Higashikawa A; Ogata N; Chung U; Nakamura K; Kawaguchi H
Osteoarthritis Cartilage; 2009 Aug; 17(8):1065-75. PubMed ID: 19254740
[TBL] [Abstract][Full Text] [Related]
40. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.
Akiyama H; Chaboissier MC; Martin JF; Schedl A; de Crombrugghe B
Genes Dev; 2002 Nov; 16(21):2813-28. PubMed ID: 12414734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
